Dr. Farhatullah Syed leads the Advanced Cell & Gene Therapy (CGT) Section at King Faisal Specialist Hospital & Research Centre (KFSH&RC), Riyadh, KSA. With over 16 years of experience from bench to clinic, he has contributed significantly to the field, authoring over 80 publications in high-impact journals and leading numerous UK-funded projects. At University College London, Dr. Syed pioneered multiple First-In-Human clinical trials using personalized cell and gene therapies and advanced genome editing. Presently at KFSH&RC, Dr. Syed’s team is at the forefront of innovation, and developing In house POC manufacturing of clinical grade vector, autologous and allogenic CAR T cells through CRISPR/Cas-based genome editing and various cell therapy ATIMPs. His research centers on the genetic manipulation of immune and stem cells, progressing from In-Vitro and In-Vivo models to clinical phase I trials. Additionally, his work at KFSHRC exploring next-generation mRNA based next generation CGTs.